Tumor Lysis Syndrome (Cairo-Bishop grading)
Tumor Lysis Syndrome (Cairo-Bishop grading) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the Tumor Lysis Syndrome (Cairo-Bishop grading) → Runs in your browser. No signup, no tracking.
What this is
Tumor Lysis Syndrome (Cairo-Bishop grading) is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. Tumor Lysis Syndrome (Cairo-Bishop grading) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004;127(1):3-11. Read the source ↗
Worked example: Clinical TLS, Cairo-Bishop grade II; 4 of 4 metabolic criteria met, creatinine 2x ULN.
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.